OncoQuest Pharmaceuticals Inc (078590) — Financial Flexibility Index
OncoQuest Pharmaceuticals Inc (078590) has a Financial Flexibility Index of -0.07x as of March 2026. Free cash flow of ₩-1.28 Billion (operating CF ₩-1.42 Billion minus capex ₩138.01 Million) represents 0% of total liabilities (₩19.38 Billion). Check how strategically is OncoQuest Pharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
OncoQuest Pharmaceuticals Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for OncoQuest Pharmaceuticals Inc across 10 annual periods. See OncoQuest Pharmaceuticals Inc (078590) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for OncoQuest Pharmaceuticals Inc (2014–2025)
Year-by-year free cash flow to debt coverage for OncoQuest Pharmaceuticals Inc. For the full company profile including market capitalisation, see how much is OncoQuest Pharmaceuticals Inc worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | ₩1.67 Billion | ₩485.35 Million | ₩32.66 Billion | ▼ -78.4% |
| 2024 | 0.24x | ₩6.48 Billion | ₩3.96 Billion | ₩27.40 Billion | ▼ -80.5% |
| 2023 | 1.21x | ₩13.08 Billion | ₩11.19 Billion | ₩10.77 Billion | ▲ +1163.8% |
| 2022 | 0.10x | ₩896.43 Million | ₩-236.91 Million | ₩9.33 Billion | ▲ +289.5% |
| 2019 | -0.05x | ₩-2.39 Billion | ₩-4.26 Billion | ₩47.21 Billion | ▼ -180.6% |
| 2018 | 0.06x | ₩2.77 Billion | ₩1.44 Billion | ₩43.95 Billion | ▼ -89.4% |
| 2017 | 0.59x | ₩6.07 Billion | ₩4.79 Billion | ₩10.21 Billion | ▼ -16.2% |
| 2016 | 0.71x | ₩5.15 Billion | ₩3.54 Billion | ₩7.26 Billion | ▼ -14.2% |
| 2015 | 0.83x | ₩5.70 Billion | ₩2.79 Billion | ₩6.89 Billion | ▲ +262.1% |
| 2014 | 0.23x | ₩2.19 Billion | ₩1.02 Billion | ₩9.61 Billion | — |